Deposition of nanoparticles in the arterial vessel by porous balloon catheters: Localization by confocal laser scanning microscopy and transmission electron microscopy

AAPS Journal

Volumn 4, Issue 4, 2002, Pages

  Westedt, Ulrich ^a   Barbu Tudoran, Lucian ^a   Schaper, Andreas K ^a   Kalinowski, Marc ^a   Alfke, Heiko ^a   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Angioplasty; Local deposition; Nanoparticles; Restenosis

Indexed keywords

EID: 52449118616     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lafont A, Guzman LA, Whitlow PL, et al. Restenosis after experimental angioplasty: intimai, medial, and adventitial changes associated with constrictive remodeling. Cire Res. 1995;76(6):996-1002.
2. Scott NA, Cipolla GD, Ross CE, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93(12):2178-2187.
3. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94(1):35-43.
4. Kimura T, Kaburagi S, Tamura T, et al. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation. 1997;96(2):475-483.
5. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res. 1990;67(3):651-659.
6. Shi Y, O'Brien JE, Ala-Kokko L, et al. Origin of extracellular matrix synthesis during coronary repair. Circulation. 1997;95(4):997-1006.
7. Hehrlein C, Gollan C, Donges K, et al. Low-dose radioactive endpvascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation. 1995;92(6):1570-1575.
8. AI-Lamee K. Surface modification of stents for improving biocompatibility. Med Device Technol. January/February 2000; 12-20.
9. Regar E, Sianos G, Serruys PW. Stent development and local drug delivery. Br Med Bull. 2001 ;59(1):227-248.
10. Wolinsky H, Thung SN. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol. 1990;15(2):475-481.
11. Muller DW, Topol EJ, Abrams GD, Gallagher KP, Ellis SG. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J Am Coll Cardiol. 1992;20(2):460-466.
12. Lambert TL, Dev V, Rechavia E, et al. Localized arterial wall drug delivery from a polymer-coated removable metallic stent: kinetics, distribution, and bioactivity of forskolin. Circulation. 1994;90(2):1003-1011.
13. Gradus-Pizlo I, Wilensky RL, March KL, et al. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery. J Am Coll Cardiol. 1995;26(6):1549-1557.
14. Wilensky RL, March KL, Hathaway DR. Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. Am Heart J. 1991;122(4, pt 1):1136-1140.
15. Wilensky RL, March KL, Gradus-Pizlo I, et al. Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters. Am Heart J. 1995 ;129(5) :852-859.
16. Nasser TK, Wilensky RL, Mehdi K, March KL. Microparticle deposition in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: quantitation and localization by confocal scanning laser microscopy. Am Heart J. 1996;131(5):892-898.
17. Valero F, Hamon M, Fournier C, et al. Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty. J Cardiovasc Pharmacol. 1998;31(4):513-519.
18. Rome J, Shayani V, Flugelman M, et al. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscl Thromb. 1994;14(1):148-161.
19. Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microparticles. Adv Drug Deliv Rev. 1997;28: 5-24.
20. Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy J. Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci. 1998;87(10):1229-1234.
21. Dev V, Eigler N, Fishbein MC, et al. Sustained local drug delivery to the arterial wall via biodegradable microspheres. Cathet Cardiovasc Diagn. 1997;41(3):324-332.
22. Guzman LA, Labhasetwar V, Song C, et al. Local intraluminal infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty. Circulation. 1996;94:1441-1448.
23. Song C, Labhasetwar V, Murphy H, et al. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Rel. 1997;43:197-212.
24. Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J Control Rel. 1998;54(2):201-211.
25. Hong MK, Wong SC, Farrb A, et al. Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery. Coron Artery Dis. 1993;4(11):1023-1027.